Treatment of Locally Advanced Pancreatic Ductal Adenocarcinoma
- PMID: 27216011
- DOI: 10.1159/000445020
Treatment of Locally Advanced Pancreatic Ductal Adenocarcinoma
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is increasingly common and a leading cause of cancer-related mortality. Surgery remains the only possibility for cure. Upwards of 40% of patients present with locally advanced PDAC (LA-PDAC), where management strategies continue to evolve. In this review, we highlight current trends in neoadjuvant chemotherapy, surgical resection, and other multimodality approaches for patients with LA-PDAC. Despite promising early results, additional work is needed to more accurately and appropriately tailor treatment for patients with LA-PDAC.
© 2016 S. Karger AG, Basel.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical